Nurix Therapeutics, Inc.NRIXNASDAQ

Revenue (LTM)

$84M

+54.0% YoY

Net Income (LTM)

$-264M

-36.6% YoY

Free Cash Flow

$-263M

Revenue CAGR (5Y)

+36.3%

Marginsimproving

FCF($0.3B)

Unprofitable

Metric	Nov 21	Nov 22	Nov 23	Nov 24	Nov 25
Revenue	30	39↑29.8%	77↑99.3%	55↓29.1%	84↑54.0%
Gross Profit	-87	-146↓68.3%	-112↑23.1%	-167↓49.0%	65↑139.0%
Operating Income	-118	-184↓56.0%	-155↑15.7%	-213↓37.4%	-286↓34.1%
Net Income	-117	-180↓53.9%	-144↑20.2%	-194↓34.5%	-264↓36.6%
EBITDA	-116	-180↓55.1%	-149↑17.1%	-205↓37.7%	-245↓19.4%
EPS Diluted	-2.73	-3.71↓35.9%	-2.65↑28.6%	-2.88↓8.7%	-3.05↓5.9%

Metric	Nov 21	Nov 22	Nov 23	Nov 24	Nov 25
Cash & Equivalents	81	64↓19.9%	55↓15.3%	110↑101.4%	247↑124.5%
Total Current Assets	311	318↑2.4%	296↓7.2%	619↑109.6%	607↓2.0%
Total Assets	477	417↓12.6%	356↓14.7%	669↑88.2%	688↑2.8%
Total Current Liabilities	66	71↑6.6%	87↑23.1%	96↑10.2%	86↓9.8%
Total Liabilities	134	113↓15.9%	155↑37.2%	142↓8.2%	149↑4.9%
Total Equity	342	304↓11.3%	200↓34.0%	527↑162.8%	539↑2.2%
Total Debt	13	12↓8.2%	31↑155.9%	28↓7.5%	56↑96.9%
Net Debt	-67	-53↑22.2%	-24↑54.3%	-82↓240.2%	-191↓134.1%

Metric	Nov 21	Nov 22	Nov 23	Nov 24	Nov 25
Operating Cash Flow	-84	-160↓89.4%	-81↑49.1%	-173↓112.1%	-249↓44.5%
Capital Expenditure	-6	-12↓116.3%	-8↑31.4%	-9↓10.4%	-14↓51.0%
Free Cash Flow	-90	-172↓91.1%	-90↑47.8%	-182↓102.6%	-263↓44.9%
Stock-Based Comp	16	28↑78.0%	34↑19.7%	34↑0.8%	38↑11.9%
Net Change in Cash	-39	-15↑60.2%	-10↑36.1%	55↑662.3%	137↑147.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance